Skip to main content
. 2014 Dec 11;9(12):e114646. doi: 10.1371/journal.pone.0114646

Figure 2. Multivariate regression analysis for axillary pNNR.

Figure 2

NAC =  neoadjuvant chemotherapy; pNNR =  pathologically node negative rate; P =  paclitaxel; Crb =  carboplatin; H =  Trastuzumab (Herceptin). In multivariate analysis, trastuzumab added and ER-poor status showed higher pNNR in HER2-positive breast cancer.